Drug intelligence / Profile preview

platinum pyrithione

Development stage
Preclinical
Modality
Small Molecules
Administration
Unknown
01

Overview

Platinum pyrithione is a **synthetic platinum complex** where platinum is coordinated with pyrithione ligands. Unlike traditional platinum-based chemotherapeutics such as cisplatin, platinum pyrithione acts through **strong, selective inhibition of proteasome-associated deubiquitinases (USP14 and UCHL5)** rather than by inducing DNA damage. This results in potent and selective cytotoxicity against a variety of cancer cell lines (including those from leukemia and ovarian cancer), with reduced toxicity in non-cancerous cells and fewer side effects in animal models. Platinum pyrithione demonstrates G2 cell cycle arrest and apoptosis in cancer cells and suppresses tumor growth in xenograft models. It is considered a promising candidate for antineoplastic therapy, particularly for tumors resistant to standard platinum drugs[1][5].

Other names
platinum pyrithionePtPT
02

Targets

UCHL5 (Ubiquitin carboxyl-terminal hydrolase isozyme L5)USP14 (Ubiquitin carboxyl-terminal hydrolase 14)

Beyond the preview

Go deeper on platinum pyrithione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platinum pyrithione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call